Overview

Pharmacokinetic Study of Paracetamol UNIFLASH (125 MG/1.25 ML)

Status:
Not yet recruiting
Trial end date:
2022-07-21
Target enrollment:
Participant gender:
Summary
This study aims to assess the pharmacokinetic profile of a new paracetamol formulation (paracetamol Uniflash 125mg/1.25mL) for buccal use after single dose.
Phase:
Phase 1
Details
Lead Sponsor:
Unither Pharmaceuticals, France
Collaborator:
Raptim Research
Treatments:
Acetaminophen